Revision history of "Induction of regulatory T cells as an inflammatory control mechanism during selective intestinal decontamination as bacterial prophylaxis in cirrhosis" (Q3180913)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 11:3811:38, 4 August 2022DG Regio talk contribs 82,083 bytes +56,997 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 19:2919:29, 12 October 2021DG Regio talk contribs 13,266 bytes +210 Changed label, description and/or aliases in en: translated_label
  • curprev 19:2919:29, 12 October 2021DG Regio talk contribs 13,056 bytes +2,587 Created claim: summary (P836): Background: Norfloxacin modulates the inflammatory response in cirrhotic patients in selective intestinal decontamination through interleukin 10 (IL10). However, the mechanism by which norfloxacin is able to stimulate the production of this cytokine is unknown. Regulator T lymphocytes exert their modulating action by secreting IL10 and TGF-B and can be induced by dendritic cells activated through different receptors. Scenario: selective intestin...

10 October 2021

9 October 2021

8 October 2021